97 related articles for article (PubMed ID: 14618213)
1. In vitro photodynamic diagnosis of atherosclerotic wall changes with the use of mono-l-aspartyl chlorin e6. A preliminary report.
Biały D; Derkacz A; Wawrzyńska M; Bednarkiewicz A; Ziółkowski P; Nowosad H; Strek W
Kardiol Pol; 2003 Oct; 59(10):293-301. PubMed ID: 14618213
[TBL] [Abstract][Full Text] [Related]
2. Direct visualization of atherosclerosis in small coronary arteries using the epifluorescence stereoscope.
Hayashi J; Saito T; Sato H; Kuroiwa Y; Aizawa K
Cardiovasc Res; 1995 Nov; 30(5):775-80. PubMed ID: 8595626
[TBL] [Abstract][Full Text] [Related]
3. Photodynamic therapy of intestinal tumors with mono-L-aspartyl chlorin e6 (NPe6): a basic study.
Kikuchi T; Asakura T; Aihara H; Shiraki M; Takagi S; Kinouchi Y; Aizawa K; Shimosegawa T
Anticancer Res; 2003; 23(6C):4897-900. PubMed ID: 14981942
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and clinical effects of mono-L-aspartyl chlorin e6 (NPe6) photodynamic therapy in adult patients with primary or secondary cancer of the skin and mucosal surfaces.
Chan AL; Juarez M; Allen R; Volz W; Albertson T
Photodermatol Photoimmunol Photomed; 2005 Apr; 21(2):72-8. PubMed ID: 15752124
[TBL] [Abstract][Full Text] [Related]
5. Photodynamic diagnosis of a human nasopharyngeal carcinoma xenograft model using the novel Chlorin e6 photosensitizer Fotolon.
Ramaswamy B; Manivasager V; Chin WW; Soo KC; Olivo M
Int J Oncol; 2005 Jun; 26(6):1501-6. PubMed ID: 15870862
[TBL] [Abstract][Full Text] [Related]
6. Transadventitial localisation of atheromatous plaques by fluorescence emission spectrum analysis of mono-L-aspartyl chlorin e6.
Hayashi J; Kuroiwa Y; Sato H; Saito T; Aizawa K
Cardiovasc Res; 1993 Nov; 27(11):1943-7. PubMed ID: 8287401
[TBL] [Abstract][Full Text] [Related]
7. [Dynamics of photosensitizer in the cell].
Aizawa K; Kuroiwa Y; Tsuchida T; Xiahedin I; Shibuya H; Saito K
Gan To Kagaku Ryoho; 1996 Jan; 23(1):22-6. PubMed ID: 8546464
[TBL] [Abstract][Full Text] [Related]
8. Insulin-mediated intracellular targeting enhances the photodynamic activity of chlorin e6.
Akhlynina TV; Rosenkranz AA; Jans DA; Sobolev AS
Cancer Res; 1995 Mar; 55(5):1014-9. PubMed ID: 7866984
[TBL] [Abstract][Full Text] [Related]
9. [Value of multi-slice computed tomography in diagnosis of coronary plaque characterization].
Xiao XG; Xie DX; Shen BZ; Han X; Li AY; Ma ZW; Zhao M; Zhang JL
Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(46):3247-50. PubMed ID: 18396617
[TBL] [Abstract][Full Text] [Related]
10. The multidrug resistance modulator SDZ-PSC 833 potentiates the photodynamic activity of chlorin e6 independently of P-glycoprotein in multidrug resistant human breast adenocarcinoma cells.
Merlin JL; Gautier H; Barberi-Heyob M; Teiten MH; Guillemin F
Int J Oncol; 2003 Apr; 22(4):733-9. PubMed ID: 12632062
[TBL] [Abstract][Full Text] [Related]
11. Detection of photodynamic therapy-induced early apoptosis in human salivary gland tumor cells in vitro and in a mouse tumor model.
Kaneko T; Chiba H; Yasuda T; Kusama K
Oral Oncol; 2004 Sep; 40(8):787-92. PubMed ID: 15288832
[TBL] [Abstract][Full Text] [Related]
12. Photodynamic diagnosis and treatment for atherosclerosis by an endoscopic approach.
Hayashi J; Saito T; Aizawa K
Diagn Ther Endosc; 1999; 5(3):191-5. PubMed ID: 18493502
[TBL] [Abstract][Full Text] [Related]
13. Photodynamic therapy with mono-L-aspartyl chlorin e6 can cause necrosis of squamous cell carcinoma of tongue: experimental study on an animal model of nude mouse.
Kobayashi W; Liu Q; Nakagawa H; Sakaki H; Teh B; Matsumiya T; Yoshida H; Imaizumi T; Satoh K; Kimura H
Oral Oncol; 2006 Jan; 42(1):46-50. PubMed ID: 16266818
[TBL] [Abstract][Full Text] [Related]
14. Characterization of human coronary artery atherosclerotic plaque fluorescence emission.
Lucas A; Radosavljevic MJ; Lu E; Gaffney EJ
Can J Cardiol; 1990; 6(6):219-28. PubMed ID: 2393833
[TBL] [Abstract][Full Text] [Related]
15. Fluorescence spectroscopic and histochemical analysis using hematoporphyrin as a microenvironmental probe for atherosclerotic change in the human aorta.
Machida M; Kameyama K; Asano G; Kumazaki T
Lab Invest; 1999 Jun; 79(6):733-45. PubMed ID: 10378516
[TBL] [Abstract][Full Text] [Related]
16. Localization of mono-L-aspartyl chlorin e6 (NPe6) in mouse tissues.
Aizawa K; Okunaka T; Ohtani T; Kawabe H; Yasunaka Y; O'Hata S; Ohtomo N; Nishimiya K; Konaka C; Kato H
Photochem Photobiol; 1987 Nov; 46(5):789-93. PubMed ID: 3441501
[No Abstract] [Full Text] [Related]
17. Effects of photodynamic therapy using a fractionated dosing of mono-L-aspartyl chlorin e6 in a murine tumor.
Webber J; Leeson B; Fromm D; Kessel D
J Photochem Photobiol B; 2005 Feb; 78(2):135-40. PubMed ID: 15664500
[TBL] [Abstract][Full Text] [Related]
18. Photodynamic activity of chlorin e6 and chlorin e6 ethylenediamide in vitro and in vivo.
Gurinovich GP; Zorina TE; Melnov SB; Melnova NI; Gurinovich IF; Grubina LA; Sarzhevskaya MV; Cherenkevich SN
J Photochem Photobiol B; 1992 Apr; 13(1):51-7. PubMed ID: 1403368
[TBL] [Abstract][Full Text] [Related]
19. Photodynamic therapy using mono-L-aspartyl chlorin e6 for rabbit experimental hepatoma.
Nakamura J; Kajiwara H
J Hepatobiliary Pancreat Surg; 1999; 6(3):312-9. PubMed ID: 10526068
[TBL] [Abstract][Full Text] [Related]
20. Noninvasive detection of subclinical coronary atherosclerosis coupled with assessment of changes in plaque characteristics using novel invasive imaging modalities: the Integrated Biomarker and Imaging Study (IBIS).
Van Mieghem CA; McFadden EP; de Feyter PJ; Bruining N; Schaar JA; Mollet NR; Cademartiri F; Goedhart D; de Winter S; Granillo GR; Valgimigli M; Mastik F; van der Steen AF; van der Giessen WJ; Sianos G; Backx B; Morel MA; van Es GA; Zalewski A; Serruys PW
J Am Coll Cardiol; 2006 Mar; 47(6):1134-42. PubMed ID: 16545642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
